Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Differential cellular effects...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Differential cellular effects of sunitinib and pazopanib targeted drugs for metastatic renal cell carcinoma

Differential cellular effects of sunitinib and pazopanib targeted drugs for metastatic renal cell carcinoma

Bibliographic Details
Main Authors: Filipa Amaro, Carolina Pisoeiro, Maria João Valente, Vera Miranda-Gonçalves, Carmen Jerónimo, Rui Henrique, Maria de Lourdes Bastos, Paula Guedes de Pinho, Márcia Carvalho, Joana Pinto
Format: Article
Language:English
Published: Rede Académica das Ciências da Saúde da Lusofonia - RACS 2022-04-01
Series:RevSALUS
Subjects:
renal cell carcinoma
tyrosine kinase inhibitors
antiproliferative
cytotoxicity
in vitro
Online Access:https://revsalus.com/index.php/RevSALUS/article/view/401
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://revsalus.com/index.php/RevSALUS/article/view/401

Similar Items

  • Metformin Use and the Outcome of Metastatic Renal Cell Carcinoma Treated with Sunitinib or Pazopanib
    by: Fiala O, et al.
    Published: (2021-05-01)
  • Therapeutic drug monitoring to personalize dosing of imatinib, sunitinib, and pazopanib: A mixed methods study on barriers and facilitators
    by: Kim Westerdijk, et al.
    Published: (2023-11-01)
  • Pazopanib as first-line therapy for patients with metastatic kidney cancer
    by: B. Ya. Alekseev, et al.
    Published: (2018-07-01)
  • Metastatic atypical renal tumour with metanephric characteristics treated with Sunitinib
    by: H. Mohammad, et al.
    Published: (2022-01-01)
  • The role of sunitinib in the therapy of metastatic renal cell carcinoma
    by: I. G. Rusakov, et al.
    Published: (2020-07-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs